REX AI Equity Premium Income ETFの空売り状況は、投資家がREX AI Equity Premium Income ETFの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

REX AI Equity Premium Income ETF (NASDAQ:AIPI), 空売り情報

The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities comprising the BITA AI Leaders Select Index (the Index). The Fund is an actively managed exchange-traded fund (ETF) that seeks capital appreciation and current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the securities of the companies comprising the Index, subject to a potential reduction in returns in a rising market.

Palantir Technologies Inc.

Arm Holdings Plc 0.00000000

NVIDIA Corporation

Crowdstrike Holdings Inc. Class A

Datadog Inc. Class A

Arista Networks, Inc

Adobe Systems Inc.

Broadcom, Inc

Palo Alto Networks Inc.

REX AI Equity Premium Income ETF

Northland Capital Markets analyst Gus Richard maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Outperform and raises the price target from $46 to $60.

News

Price Target

Analyst Ratings

SMTC

Northland Capital Markets Maintains Outperform on Semtech, Raises Price Target to $60

WIIM

AMGN

Amgen shares are trading lower following the results of its Phase 2 study with MariTide in obesity.

Kohl's shares are trading lower after the company reported worse-than-expected Q3 EPS and sales, cut its FY24 EPS guidance, and projected a net sales decrease of 7%-8%.

Keybanc analyst Jason Celino maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Overweight and raises the price target from $62 to $74.

GTLB

Keybanc Maintains Overweight on GitLab, Raises Price Target to $74

Novo Nordisk and Eli Lilly shares are trading higher after the Biden-Harris administration proposed a new step to expand coverage of anti-obesity medications for Medicare and Medicaid beneficiaries.

Guidance

Canopy Growth Board Reaffirms Confidence In Company's Strategic Direction

LDTC

LeddarTech Achieves ISO/IEC 27001 Certification, Strengthening Cybersecurity Framework

Keybanc analyst Justin Patterson maintains Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Overweight and raises the price target from $38 to $55.

GLBE

Keybanc Maintains Overweight on Global E Online, Raises Price Target to $55

Wells Fargo initiates coverage on Thomson Reuters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRI#NYSE">TRI</a>) with a Equal-Weight rating and announces Price Target of $165.

Initiation

Wells Fargo Initiates Coverage On Thomson Reuters with Equal-Weight Rating, Announces Price Target of $165

AVXL

Anavex Life Sciences Submits Blarcamesine Marketing Authorization Application To EMA For Alzheimer's Disease Treatment Approval

Management

Canopy Growth Names Current Board Member Luc Mongeau As Its Next CEO, Effective January 6, 2025

SL Green Realty Enters Contract To Purchase 500 Park Avenue For $130M

DCGO

DocGo Secures Two-Year Contract With Major Texas Health System For Medical Transportation Services

The FDA will review the updated sBLA within four months of submission. Theratechnologies therefore expects a decision around the end of March 2025. The new formulation is patent protected in the U.S. until 2033.

THTX

Theratechnologies Resubmits Supplemental Biologics License Application To FDA For F8 Formulation Of Tesamorelin

Abercrombie & Fitch Increases Full Year Outlook To Net Sales Growth Outlook From 12% - 13% To 14% -15%; Sees Q4 Net Sales To Grow 5% - 7%

Guggenheim analyst Robert Drbul upgrades Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) from Neutral to Buy and announces $30 price target.

Upgrades

CPRI

Guggenheim Upgrades Capri Holdings to Buy, Announces $30 Price Target

Wells Fargo analyst Matthew Akers upgrades Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) from Equal-Weight to Overweight and lowers the price target from $157 to $147.

SAIC

Wells Fargo Upgrades Science Applications Intl to Overweight, Lowers Price Target to $147

CGTX

Cognition Therapeutics Announces Completion of Final Visits In Phase 2 SHIMMER Study Of CT1812 For Dementia With Lewy Bodies

In his new role, Ball will serve on the company's executive leadership team and continue to report to Scott Lipesky, Executive Vice President and Chief Operating Officer.
Lipesky, who served as the company's CFO since 2017, was promoted to COO in May 2023, and will remain in that role, leading the company's global operations and growth strategies, while driving financial discipline, capital allocation and efficiency.
&nbsp;

Abercrombie & Fitch Names Robert Ball As CFO, Effective November 20, 2024

ifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
The Board determined that Danone's $27.00 per share proposal substantially undervalues the Company. The Board is not, however, opposed to the sale of the Company at any price.
The Board has carefully evaluated the Company's standalone plan&nbsp;and believes it has strong potential to provide superior value to all shareholders as compared to Danone's revised proposal. The Board takes its fiduciary duties seriously and is committed to acting in the best interests of all of the Company's shareholders and other stakeholders.

DANOY

LWAY

Lifeway Foods Rejects Danone's $27 Per Share Acquisition Proposal, Citing Undervaluation Of The Company

Dividend Harvesting Portfolio Week 181: $18,100 Allocated, $1,657.29 In Projected Dividends

The new REX AI Equity Premium Income ETF ($AIPI) combines a portfolio of AI stocks with a jaw-dropping yield of 35.1% (based on its distribution ra...

New AIPI ETF Combines AI Stocks with a Jaw-dropping Yield

REX AI Equity Premium Income ETF goes ex dividend today

Dividend Harvesting Portfolio Week 182: $18,200 Allocated, $1,678.32 In Projected Dividends

Dividend Harvesting Portfolio Week 185: $18,500 Allocated, $1,726.55 In Projected Dividends

Dividend Harvesting Portfolio Week 188: $18,800 Allocated, $1,764.21 In Projected Dividends

Dividend Harvesting Portfolio Week 192: $19,200 Allocated, $1,836.34 In Projected Dividends

AIPI: A Complement To Your Income Portfolio, Depending On Your Take On AI

AIPI: A Covered Call Strategy With AI Exposure

AIPI

ARCC

BXSL

FEPI

PLTR

QQQI

SPYI

Press Releases

REX Shares Launches New Covered Call ETF Targeting AI Market Leaders for Enhanced Income Opportunities

Comments

REX AI Equity Premium Income ETF

空売り

REX AI Equity Premium Income ETF (NASDAQ:AIPI), 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル